Indication
Erysipelas
Erysipelas is an acute superficial bacterial infection of the skin that primarily involves the upper dermis and extends into the superficial cutaneous lymphatics. Read more about Erysipelas
25 drugs 21 manufacturers
Drugs that treat it
Common Erysipelas therapies.
PENICILLIN V POTASSIUM
PENICILLIN V POTASSIUM
PENICILLIN V POTASSIUM
PENICILLIN V POTASSIUM
PENICILLIN V POTASSIUM
PENICILLIN V POTASSIUM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonErysipelas is an acute superficial bacterial infection of the skin that primarily involves the upper dermis and extends into the superficial cutaneous lymphatics.
It can occur in both pediatric and adult populations, most frequently presenting on the lower extremities and the face following a break in the cutaneous barrier.
Pathophysiologically, it is most often caused by beta-hemolytic streptococci, particularly group A *Streptococcus* (*Streptococcus pyogenes*).
The condition is clinically distinguished by a rapid onset of intense warmth, edema, and a bright red, indurated plaque characterized by sharply demarcated, raised borders, often accompanied by systemic features such as acute fever, chills, and regional lymphadenopathy.
- nih.gov
Erysipelas is an acute superficial bacterial infection of the skin that primarily involves the upper dermis and extends into the superficial cutaneous lymphatics It can occur in both pediatric and adult populations, most frequently presenting on the lower extremities and the face following a break in the cutaneous barrier The condition is clinically distinguished by a rapid onset of intense warmth, edema, and a bright red, indurated plaque characterized by sharply demarcated, raised borders, oft...
- merckmanuals.com
Erysipelas is an acute superficial bacterial infection of the skin that primarily involves the upper dermis and extends into the superficial cutaneous lymphatics It can occur in both pediatric and adult populations, most frequently presenting on the lower extremities and the face following a break in the cutaneous barrier Pathophysiologically, it is most often caused by beta-hemolytic streptococci, particularly group A *Streptococcus* (*Streptococcus pyogenes*)
- nih.gov
The condition is clinically distinguished by a rapid onset of intense warmth, edema, and a bright red, indurated plaque characterized by sharply demarcated, raised borders, often accompanied by systemic features such as acute fever, chills, and regional lymphadenopathy
- nih.gov
The condition is clinically distinguished by a rapid onset of intense warmth, edema, and a bright red, indurated plaque characterized by sharply demarcated, raised borders, often accompanied by systemic features such as acute fever, chills, and regional lymphadenopathy
Personalize your experience
Follow Erysipelas and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.